Sutton Wealth Advisors Inc. Cytokinetics Inc Transaction History

Sutton Wealth Advisors Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$33.36 - $45.71 $68,287 - $93,568	-2,047 Closed	0 $0
Q4 2022 Nov 07, 2023	BUY	$35.77 - $51.11 $35 - $51	1 Added 0.05%	2,047 $93.8 Million
Q3 2022 Nov 07, 2023	BUY	$38.54 - $54.52 $192 - $272	5 Added 0.24%	2,046 $99.1 Million
Q2 2022 Nov 07, 2023	SELL	$33.93 - $48.92 $135 - $195	-4 Reduced 0.2%	2,041 $80.2 Million
Q1 2022 Nov 07, 2023	SELL	$29.74 - $46.0 $29 - $46	-1 Reduced 0.05%	2,045 $75.3 Million
Q4 2021 Nov 07, 2023	BUY	$34.35 - $46.38 $687 - $927	20 Added 0.99%	2,046 $93.3 Million
Q3 2020 Nov 07, 2023	SELL	$20.58 - $28.96 $493 - $695	-24 Reduced 1.17%	2,026 $43.9 Million
Q2 2020 Nov 07, 2023	SELL	$11.15 - $24.64 $1,795 - $3,967	-161 Reduced 7.28%	2,050 $48.3 Million
Q1 2019 Nov 06, 2023	BUY	$5.95 - $10.19 $13,155 - $22,530	2,211 New	2,211 $17.9 Million
Q4 2018 Nov 06, 2023	SELL	$5.91 - $9.29 $5,679 - $8,927	-961 Closed	0 $0
Q3 2018 Nov 06, 2023	BUY	$6.4 - $9.85 $2,156 - $3,319	337 Added 54.01%	961 $9.47 Million
Q3 2017 Nov 06, 2023	BUY	$12.0 - $15.0 $960 - $1,200	80 Added 14.71%	624 $9.05 Million
Q2 2017 Nov 06, 2023	BUY	N/A	544	544 $6.58 Million

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.92B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.